Mylan has settled issues raised by the US government over the price of its EpiPen autoinjector pen, paying a settlement of $465 million. Shares in the company surged yesterday following the news ...

The pivot came amid pressure to cut the price of the drug that's up 500% since Mylan acquired it in 2007. "The system is broken. Look, first and foremost we want everyone with an EpiPen to have one.

Sanofi claims its Auvi-Q, a more portable epinephrine autoinjector with a retractable needle and audio instructions, couldn't compete on the unlevel playing field Mylan created for its EpiPen. (CN) — ...

The furore over Mylan’s ‘price gouging’ in relation to EpiPen in the US went global, thanks to social media. Daniel Ghinn examines the reaction of healthcare professionals on social media ...

Members of the Senate Finance Committee have questions about EpiPen-maker Mylan's relationship with Medicaid. They just sent a letter to Daniel Levinson, the Inspector General of the US Department ...

One EpiPen auto-injector from Mylan contains about one-third of a milliliter. When Mylan acquired the auto injectors as part of a 2007 deal, they were priced at about $57, according to Truven ...

CVS (operating in Hawaii as Longs Drugs) is now selling a rival, generic version of Mylan’s EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment ...

EpiPen's classification as a generic drug prevents it from receiving mandated rebates. Mylan provided documentation it said showed the military had accepted the generic classification for EpiPen ...

But problems in the production of EpiPen, the biggest brand of adrenaline auto-injector (AAI) on the market, have led to a shortage. The distributors, Mylan, said supply problems were due to ...

Injectable products, like Mylan’s EpiPen (epinephrine injection), are currently the go-to treatment for patients undergoing ...

However, as of May 2018, Mylan’s brand-name EpiPen, as well as its authorized generic, Adrenaclick, were all added to the Food and Drug Administration’s drug shortage list. That means those ...

At its worst, anaphylaxis is bad news of the kill-you-dead variety, which makes having an EpiPen or two around very handy indeed. Bresch’s company, Mylan, recently raised prices on the EpiPen ...